- Home
- ANEB vs AAME Comparison
ANEB vs AAME Comparison
Compare ANEB & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- AAME
- Stock Information
- Founded
- ANEB 2020
- AAME 1968
- Country
- ANEB United States
- AAME United States
- Employees
- ANEB N/A
- AAME N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- AAME Life Insurance
- Sector
- ANEB Health Care
- AAME Finance
- Exchange
- ANEB Nasdaq
- AAME Nasdaq
- Market Cap
- ANEB 111.8M
- AAME 56.6M
- IPO Year
- ANEB 2021
- AAME N/A
- Fundamental
- Price
- ANEB $2.74
- AAME $3.14
- Analyst Decision
- ANEB Buy
- AAME
- Analyst Count
- ANEB 2
- AAME 0
- Target Price
- ANEB $8.00
- AAME N/A
- AVG Volume (30 Days)
- ANEB 27.8K
- AAME 23.0K
- Earning Date
- ANEB 11-12-2025
- AAME 11-11-2025
- Dividend Yield
- ANEB N/A
- AAME 0.64%
- EPS Growth
- ANEB N/A
- AAME N/A
- EPS
- ANEB N/A
- AAME 0.10
- Revenue
- ANEB N/A
- AAME $198,977,000.00
- Revenue This Year
- ANEB N/A
- AAME N/A
- Revenue Next Year
- ANEB N/A
- AAME N/A
- P/E Ratio
- ANEB N/A
- AAME $28.98
- Revenue Growth
- ANEB N/A
- AAME 6.98
- 52 Week Low
- ANEB $0.80
- AAME $1.25
- 52 Week High
- ANEB $3.42
- AAME $3.71
- Technical
- Relative Strength Index (RSI)
- ANEB 63.12
- AAME 58.06
- Support Level
- ANEB $2.50
- AAME $2.92
- Resistance Level
- ANEB $2.85
- AAME $3.17
- Average True Range (ATR)
- ANEB 0.14
- AAME 0.15
- MACD
- ANEB 0.04
- AAME 0.03
- Stochastic Oscillator
- ANEB 81.45
- AAME 94.97
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.